Late relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study.

@article{Provencio2010LateRI,
  title={Late relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study.},
  author={Mariano Provencio and C. Sancho de Salas and Isabel Mill{\'a}n and Blanca Cantos and Antonio Cano S{\'a}nchez and Carmen Bellas},
  journal={Leukemia & lymphoma},
  year={2010},
  volume={51 9},
  pages={1686-91}
}
Survival in Hodgkin lymphoma (HL) has significantly increased, and most relapses occur in the first 2 years. We analyzed the proportion of relapses occurring after 5 years, the method of detection, and survival in the database of patients with HL in our hospital (1967-2005). We undertook a retrospective study of clinical and molecular characteristics with the use of 12 different antibodies (Abs): CD30, CD15, CD20, CD3, BCL-2, BCL-6, CD57, EMA, p53, Ki-67, Aurora kinase A, and PAX-5. We studied… CONTINUE READING